The Venture Codex Logo

The Venture Codex

TAUNS Laboratories

761-1 Kamishima, Izunokuni-shi, Shizuoka, 410-2325, Japan

Overview

In vitro diagnostics and research reagents for infectious diseases.

Deals · 12mo

2

Links

WebsiteLinkedIn

Stage focus

Series B
Series C
Series D

Geographic focus

Japan

Sector focus

Biopharma
Health Diagnostics

Investment portfolio

3rounds
NAMEDATESIZE
Craif
Aug 2026Led
$34 MSeries D
EMC Healthcare
Jan 2026Participated
$4 MSeries B
Craif
Apr 2025Participated
$22 MSeries C
Craif
Aug 2026Led
$34 MSeries D
EMC Healthcare
Jan 2026Participated
$4 MSeries B
Craif
Apr 2025Participated
$22 MSeries C
3
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

TAUNS Laboratories: 3 funding rounds are recorded in the selected participation categories.All available history.
TAUNS Laboratories: 3 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series B01
Series C+11

Monthly Deal Activity

TAUNS Laboratories: 3 deals are recorded across 19 months.All available history.
TAUNS Laboratories: 3 deals are recorded across 19 months. All available history
MonthDeals
Apr '251
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '261
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '261
Sep '260
Oct '260

Sector Breakdown

TAUNS Laboratories: Health & Life Sciences is the largest displayed sector by deal count (3 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

TAUNS Laboratories: Health & Life Sciences is the largest displayed sector by deal count (3 deals). All available history
SectorDeals
Health & Life Sciences3
AI & Machine Learning3
Professional Services1
Data, Analytics & IT1

Deal Size Distribution

TAUNS Laboratories: 3 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

TAUNS Laboratories: 3 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M1
$5M-$10M0
$10M-$25M1
$25M-$50M1
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

TAUNS Laboratories: Japan has the largest recorded deal count among the displayed regions (3 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

TAUNS Laboratories: Japan has the largest recorded deal count among the displayed regions (3 deals). All available history
RegionDeals
Japan3
TAUNS Laboratories: 7 co-investors are shown, with Unreasonable Collective sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

TAUNS Laboratories: 7 co-investors are shown, with Unreasonable Collective sharing 2 recorded deals. All available history
Co-investorShared deals
Unreasonable Collective2
X&KSK2
Aozora Bank1
Daiwa House Ventures1
Granite Asia1
Integral Corporation1
Miraidoa (Future Venture Capital)1

Investment Strategy

TAUNS Laboratories: Led accounts for 33% and participating for 67% of round participation.All available history.
TAUNS Laboratories: Led accounts for 33% and participating for 67% of round participation. All available history
CategoryDeals (count)Share (%)
Led133%
Participating267%
TAUNS Laboratories: Single-lead accounts for 0% and co-led for 100% of lead dynamics.All available history.
TAUNS Laboratories: Single-lead accounts for 0% and co-led for 100% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led1100%

Team

Masaki Nonaka

CEO & President